PierianDx Partners with Florida Cancer Specialists & Research Institute to Advance Cancer Care

Meyer Ventures was a Lead Investor in PierianDx in 2015 alongside Healthcare Capital Catalyst Management and Anthony E. Meyer serves…

Previously, Pad-in-Motion, Equiva announces a SaaS tablet bundle for improved patient experience and digital health engagement

Meyer Ventures was a “Lead Seed Investor” in Pad-in-Motion in 2014. In 2021, Pad-in-Motion rebranded to Equiva Health.

PierianDx Announces Expanded Partnership with Illumina to Support Cancer Genomic Reporting in Global Markets

Meyer Ventures was a Lead Investor in PierianDx in 2015 alongside Healthcare Capital Catalyst Management.

Volastra Therapeutics Launches with $12 Million in Seed Financing to Develop Novel Metastatic Cancer Therapies

Affiliates of Ocean Road Advisors and Meyer Ventures provided seed financing for the formation and commercialization of Volastra from Weill…

Agios’ Lewis Cantley returns with a new company; Volastra Therapeutics and, he claims, a major oncological discovery

Affiliates of Ocean Road Advisors and Meyer Ventures provided seed financing for the formation of Volastra Therapeutics.

PierianDx Closes Series B Financing Round to Facilitate the Democratization of Clinical Next-Generation Sequencing

Meyer Ventures was a Lead Investor in PierianDx in 2015 alongside Healthcare Capital Catalyst Management.

Horwitz Prize Awarded For Work on Critical Cancer Pathway

Lewis C. Cantley is the Director of the Meyer Cancer Center at Weill Cornell Medicine.

Weill Cornell Medicine Experiences Dynamic Growth in Research Funding

Weill Cornell Medicine’s research enterprise has expanded greatly in recent years

PierianDx Announces Multi-Year Agreement with Illumina to Support Cancer Research and Diagnostics

Ocean Road Advisors is a co-lead Investor in PierianDx’s recent Series A financing alongside Health Catalyst Capital Management.

HealthMine CEO, Bryce Williams, presenting at the RISE Star Ratings Master Class: “Improving star quality ratings: how to think like a start-up to drive clinical health action”

Meyer Ventures is an investor in HealthMine, and Anthony Meyer serves on its Board of Directors.